Pharmaceutical clearance
where the cold chain
doesn't wait for paperwork.
NMRC Section 22 permits tracked before goods ship. Direct vessel-to-cold-store coordination at Namport. Chapter 30 classification and EML zero-rating applied correctly. Controlled substances handled with the additional authorisation layer built into the timeline.
What we handle
Three pharmaceutical import scenarios. Each with a different risk point.
Cold-chain pharmaceutical consignment
2–8°C refrigerated medicines or -80°C biologics/vaccines arriving by sea. Direct vessel-to-cold-store coordination at Namport arranged before vessel arrival. NamRA examination flagged as temperature-sensitive — examination conducted in cold conditions, not at ambient.
Wrong: allowing the consignment to go to general cargo storage while documentation is resolved. A temperature excursion during the clearance period is a product integrity event, not a paperwork problem.
Registered medicine — routine import cycle
Established pharmaceutical distributor with NamRA import history. Each consignment covered by a Section 22 permit obtained before goods ship. Chapter 30 subheadings consistent across declaration history. VAT zero-rating applied to EML products. Permit reference in Box 44 every time.
Wrong: applying for the permit after goods arrive. NMRC processing is 5–15 working days for standard products. Goods detained at port during this period accumulate demurrage and cold-store charges.
Controlled substance import
Schedule 1/2 narcotics or psychotropic medications for hospital or specialty pharmacy supply. Additional import authorisation from the narcotics authority required alongside the NMRC Section 22 permit. Audit trail from exporter to Namibian licensed importer to end-user maintained as a regulatory obligation.
Wrong: treating controlled substances as standard pharma. The additional authorisation layer adds lead time. Build it into the procurement cycle — not as a last-minute item when the goods are already in transit.
Scope of service
Both regulatory tracks,
coordinated from
one point.
Pharmaceutical clearance at Walvis Bay requires the NamRA customs track and the NMRC regulatory track to converge before goods can be released. We manage both — permit status tracking, cold-store coordination, correct classification, and examination management — so neither track is the bottleneck.
Discuss your import programmeTechnical guides
Understand the dual regulatory framework before you ship.
Pharmaceutical and Cold-Chain Import Clearance at Walvis Bay
NMRC permit procedures, Chapter 30 classification, cold-chain port handling, and controlled substances requirements — the full picture.
Read guideNamRA Advance Tariff Rulings: Binding Classification Before You Ship
How to get a binding HS classification on pharmaceutical products before your first shipment.
Read guideCustoms Valuation Disputes at NamRA
If NamRA challenges the declared value of pharmaceutical imports — the WTO CVA hierarchy and how to respond.
Read guideCustoms Compliance Audits in Namibia
How NamRA's post-clearance audit examines declaration accuracy, VAT treatment, and permit compliance across a 2–3 year period.
Read guideGet in touch
Tell us about your import programme.
Product type, volume, cold-chain requirements. We'll outline the clearance approach and permit timeline.